XT
PCVX icon

XTX Topco’s Vaxcyte PCVX Stock Holding History

XTX Topco’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$876K Sell
15,081
-180
-1% -$9.77K 0.02% 1534
2025
Q4 		$704K Buy
+15,261
New +$683K 0.02% 1310
2025
Q3 		– Sell
-41,678
Closed -$1.35M – 3096
2025
Q2 		$1.35M Buy
41,678
+27,882
+202% +$914K 0.06% 504
2025
Q1 		$521K Buy
13,796
+10,770
+356% +$861K 0.03% 1001
2024
Q4 		$248K Buy
+3,026
New +$300K 0.02% 1375
2023
Q4 		– Sell
-4,696
Closed -$239K – 1984
2023
Q3 		$239K Sell
4,696
-670
-12% -$33.1K 0.04% 899
2023
Q2 		$268K Sell
5,366
-4,363
-45% -$207K 0.05% 801
2023
Q1 		$365K Buy
+9,729
New +$413K 0.08% 499

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return